Investigating psychiatric and cognitive traits in specific genetic syndromes

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to explore the psychiatric and cognitive phenotypes associated with Velocardiofacial Syndrome, Williams Syndrome, and Fragile X Syndrome. It involves administering treatments such as methylphenidate, fluoxetine, and risperidone to assess their effects on these phenotypes. The research will also examine the connections between these traits and developmental as well as molecular factors. By characterizing these conditions, the study seeks to enhance understanding and treatment options for affected individuals.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* chromosomal deletion proven by FISH examination

Exclusion Criteria:

Where it's running

• Schneider Children's Mediac Center of Israel
  Petah Tikva, Israel Recruiting

Study contacts

• Study coordinator: Doron Gothelf, MD
• Email: gothelf@post.tau.ac.il
• Phone: 972-03-5302663

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Inclusive physical activity program for adults with intellectual disabilities

  This study is testing a new fitness program for adults with intellectual disabilities to see if it helps them be more active and feel better over 16 weeks.

  Recruiting University of North Carolina, Chapel Hill · Fayetteville, Arkansas and 1 other locations · NCT06740162

• CTH120 in Fragile X syndrome: safety and early effectiveness in adult males

  This study tests CTH120 versus placebo to see if it is safe and helps adults with Fragile X syndrome.

  Recruiting at 2 sites Phase 2 Connecta Therapeutics, S.L. · Barcelona, Barcelona and 1 other locations · NCT07654114

• Two-week intensive brain-focused therapy program for children with neurodevelopmental and chromosomal conditions

  This program will try a two-week, individualized multimodal neurorehabilitation approach for children about 4–12 years old with neurodevelopmental or chromosomal conditions to see if it improves attention, motor skills, communication, and daily functioning.

  Recruiting Healing Hope International · The Woodlands, Texas · NCT07493096

• How phonology and sound sensitivity shape language in people with Williams syndrome

  This project tries to see if sensitivity to sound (hyperacusis) and reliance on phonological short-term memory explain why people with Williams syndrome often have strong verbal skills by comparing them to individuals with Down syndrome and typically developing peers using EEG-NIRS and questionnaires.

  Recruiting Centre Hospitalier Universitaire, Amiens · Amiens · NCT07285720

• MRM-3379 for males with Fragile X Syndrome (BLOOM)

  This trial will test three doses of the oral drug MRM-3379 in males with Fragile X Syndrome aged 16–45 (placebo-controlled), with a parallel open-label group for ages 13–15.

  Recruiting at 17 sites Phase 2 Mirum Pharmaceuticals, Inc. · Phoenix, Arizona and 17 other locations · NCT07209462

• Understanding Williams Syndrome and related chromosome variants

  This study is looking to learn more about the development, health, and behavior of people with Williams syndrome and related chromosome changes by collecting samples and information from them and their families.

  Recruiting University of Pennsylvania · Philadelphia, Pennsylvania · NCT06930417

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.